Clinical Trials Directory

Trials / Completed

CompletedNCT02310698

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

Status
Completed
Phase
Study type
Observational
Enrollment
487 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Not accepted

Summary

Breast tumors are often detected on mammography but may be harder to see in women with dense breasts. This is why screening breast ultrasound is sometimes used as another test in women with dense breasts. Ultrasound has been shown to detect additional cancers that are not seen on regular mammography. Contrast Enhanced Digital Mammography (CEDM) is a FDA approved form of mammography. It is essentially a routine digital mammogram performed after iodine dye (the same that is used with CT scans) is injected into a vein in the arm. Like screening ultrasound, CEDM has been shown to detect breast cancers that are not seen on a regular mammogram. The purpose of this study is to compare whether CEDM or screening breast ultrasound is better at detecting cancer. Both will be done in this study and compared to one another.

Conditions

Interventions

TypeNameDescription
DEVICEcontrast enhanced digital mammography (CEDM)
DEVICEwhole breast screening ultrasound (WBUS)

Timeline

Start date
2014-12-02
Primary completion
2025-03-26
Completion
2025-03-26
First posted
2014-12-08
Last updated
2025-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02310698. Inclusion in this directory is not an endorsement.